London is fast emerging as a global centre for life sciences – pharmaceuticals, biotech, medical devices & supporting activities- and the sector has grown more than 7% annually since 2018, making it the highest area of growth in the UK. As this rapidly growing industry continues to expand, its influence on the city’s built landscape is becoming increasingly significant.
This event will delve into topics such as the integration of cutting-edge laboratories and research facilities into the urban fabric, the role of sustainable design in supporting life sciences infrastructure, and how these developments can contribute to broader urban regeneration efforts. They’ll also explore the challenges and opportunities posed by this growth, from ensuring community engagement to balancing the needs of a thriving industry with preserving the city’s cultural and historical heritage.
The London Society is delighted to host Dr Angela Kukula, CEO of MedCity, to discuss the opportunities and challenges that growth in life sciences is bringing to London. Founded by the Mayor of London in partnership with the city’s Academic Health Science Centres, MedCity fosters international collaborations between biotech, medtech and pharma companies and the capital’s world-leading life sciences ecosystem to supercharge innovation, drive inward investment and build skills and talent across the sector in the UK.
Other speakers include Billy Choi, head of Life Science projects at Allies and Morrison, our hosts for the evening, and a collection of other key voices in the sector. The discussion will be led by London Society Health trustee Clare Delmar.
In the build up to this event, please feel free to share via social media: 
#LondonSociety2024
#LoveLondon
@londonsoc